Dr. Nate Radcliffe shares his thoughts on how expanding access to and delivery of SLT poses a great challenge. DSLT can help change that.
Watch this EyeWire TV feature announcing BELKIN Vision's CE Mark
Feature: From Too Few Drops to DSLT - An Interview With Prof Gerd Auffarth
Health Supplement Feature: Vision of the future for Glaucoma
The State of SLT: Advancing the Technology and its Adoption
Interview: Professor Augusto Azuara-Blanco discusses glaucoma treatment in the blink of an eye
Interview: The Israeli Startup Treating the Silent Thief of Sight
Remote Diagnosis and Treatment of Glaucoma: DSLT's application in telemedicine
BELKIN Vision wins €17.5M from the EU Innovation Council
Watch CEO Daria Lemann Blumenthal in this interview on i24News about our disruptive DSLT glaucoma treatment.
Developing DSLT - Interview with Prof Michael Belkin
Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology
The Glaucoma Treatment That Only Takes Seconds
Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.
Read this candid interview with CEO Daria Lemann-Blumenthal
Opinion piece on 'Glaucoma care in a matter of seconds'
Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.
BELKIN Vision Completes $12.25 Series B Financing Round
BELKIN Vision Announces $12.2M Raised in Series B Funding
Pushing Boundaries with Advanced Technologies
Company Showcase
Emerging Glaucoma Devices See Beyond IOP
BELKIN Vision COVID-19 update
New Technologies Change Glaucoma Treatment Paradigm
Get our latest news and updates!
Subscribe to receive BELKIN Vision's Newsletter with the latest news and clinical updates.